“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”

Vasomotor symptoms (VMS) are a common and distressing experience during menopause, affecting a significant portion of women. Hormone therapy (HT) has been the traditional treatment, but its limitations and potential risks have led to the search foar non‐hormonal alternatives. Recently, the FDA appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaukat, Ayesha, Mujeeb, Azka, Shahnoor, Syeda, Nasser, Nathalie, Khan, Abdul Moiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551868/
https://www.ncbi.nlm.nih.gov/pubmed/37808928
http://dx.doi.org/10.1002/hsr2.1610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551868/
https://www.ncbi.nlm.nih.gov/pubmed/37808928
http://dx.doi.org/10.1002/hsr2.1610

Ejemplares similares